Search research articles
Contact Us
Filters
Showing results (271-280 of 476) with videos related to
Page
of 48
Sort By:
Parkinsonism & Related Disorders
|
December 2, 2008
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease
Yulia Golub, Daniela Berg, Donald B Calne, et al.
Neurobiology of Disease
|
February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 24, 2020
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
Stefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 8, 2013
No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's disease
Silke Appenzeller, Claudia Schulte, Sandra Thier, et al.
Annals of Neurology
|
September 22, 2015
Is the MC1R variant p.R160W associated with Parkinson's?
Steven J Lubbe, Valentina Escott-Price, Alexis Brice, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 27, 2018
Parkinson's disease: evolution of cognitive impairment and CSF Aβ<sub>1-42</sub> profiles in a prospective longitudinal study
Stefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 23, 2018
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease
Stefanie Lerche, Inga Liepelt-Scarfone, Isabel Wurster, et al.
Molecular Neurobiology
|
November 26, 2025
Cellular and Extracellular MicroRNA Dysregulation in LRRK2-Linked Parkinson's Disease
Felix Knab, Jun-Hoe Lee, Raja Nirujogi, et al.
Nature Reviews. Drug Discovery
|
May 3, 2011
Priorities in Parkinson's disease research
Wassilios G Meissner, Mark Frasier, Thomas Gasser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 28, 2021
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB
Stefanie Lerche, Simon Sjödin, Ann Brinkmalm, et al.
Page
of 48
Search research articles
Search
Showing results (271-280 of 476) with videos related to
Sort By:
Page
of 48
Parkinsonism & Related Disorders
|
December 2, 2008
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease
Yulia Golub, Daniela Berg, Donald B Calne, et al.
Neurobiology of Disease
|
February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 24, 2020
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
Stefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 8, 2013
No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's disease
Silke Appenzeller, Claudia Schulte, Sandra Thier, et al.
Annals of Neurology
|
September 22, 2015
Is the MC1R variant p.R160W associated with Parkinson's?
Steven J Lubbe, Valentina Escott-Price, Alexis Brice, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 27, 2018
Parkinson's disease: evolution of cognitive impairment and CSF Aβ<sub>1-42</sub> profiles in a prospective longitudinal study
Stefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 23, 2018
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease
Stefanie Lerche, Inga Liepelt-Scarfone, Isabel Wurster, et al.
Molecular Neurobiology
|
November 26, 2025
Cellular and Extracellular MicroRNA Dysregulation in LRRK2-Linked Parkinson's Disease
Felix Knab, Jun-Hoe Lee, Raja Nirujogi, et al.
Nature Reviews. Drug Discovery
|
May 3, 2011
Priorities in Parkinson's disease research
Wassilios G Meissner, Mark Frasier, Thomas Gasser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 28, 2021
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB
Stefanie Lerche, Simon Sjödin, Ann Brinkmalm, et al.
Page
of 48